Senior Director
WuXi Biologics US
Dr. Steven Ren is a distinguished scientist with extensive expertise in CMC management, product development, manufacturing, and testing of biologics and small molecules. As Senior Director of CMC Management at WuXi Biologics US LLC, he oversees early- and late-stage biologics development projects. His career includes key contributions at Evive Biotechnology, Teva Pharmaceuticals, GlaxoSmithKline, Allergan, and Amylin Pharmaceuticals, with a strong focus on biologics development and global regulatory submissions. His research interests center on CMC development, particularly formulation, drug product development, manufacturing and testing of parenteral dosage forms, including vials, prefilled syringes, and autoinjectors. Dr. Ren has published over 15 peer-reviewed articles, authored three book chapters, and holds three patents. His recent review, Effects of Arginine in Therapeutic Protein Formulations: A Decade Review and Perspectives, has been widely recognized in the biopharmaceutical community. He earned his Ph.D. in Pharmaceutical Sciences from the University of Southern California.